Eke, P. I., Dye, B. A., Wei, L., Thornton-Evans, G. O. & Genco, R. J. & Cdc Periodontal Disease Surveillance workgroup: James Beck, G. D. R. P. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J. Dent. Res. 91, 914–920 (2012).
Nazir, M. A. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J. Health Sci. 11, 72–80 (2017).
Chen, M. X., Zhong, Y. J., Dong, Q. Q., Wong, H. M. & Wen, Y. F. Global, regional, and national burden of severe periodontitis, 1990-2019: An analysis of the Global Burden of Disease Study 2019. J. Clin. Periodontol. 48, 1165–1188 (2021).
Buhlin, K., Gustafsson, A., Pockley, A. G., Frostegard, J. & Klinge, B. Risk factors for cardiovascular disease in patients with periodontitis. Eur. Heart J. 24, 2099–2107 (2003).
Sanz, M. et al. Periodontitis and Cardiovascular Diseases. Consensus Report. Glob. Heart 15, 1 (2020).
Chambrone, L. et al. Periodontitis and chronic kidney disease: a systematic review of the association of diseases and the effect of periodontal treatment on estimated glomerular filtration rate. J. Clin. Periodontol. 40, 443–456 (2013).
Parsegian, K., Randall, D., Curtis, M. & Ioannidou, E. Association between periodontitis and chronic kidney disease. Periodontol 2000 89, 114–124 (2022).
Francis, A. et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat. Rev. Nephrol. 20, 473–485 (2024).
Tangri, N. et al. Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study. BMJ Open 13, e067386 (2023).
Bikbov, B., Purcell, C. A., Levey, A. S., Smith, M. & Abdoli, A. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709-733 (2020).
Webster, A. C., Nagler, E. V., Morton, R. L. & Masson, P. Chronic kidney disease. Lancet 389, 1238–1252 (2017).
Fisher, M. A. et al. Periodontal disease and other nontraditional risk factors for CKD. Am. J. Kidney Dis. 51, 45–52 (2008).
Kotecha, K. et al. High prevalence of periodontal disease observed in patients on hemodialysis: a call for equitable access to dental care. Kidney Int Rep. 7, 2097–2100 (2022).
Dannewitz, B. et al. Status of periodontal health in German patients suffering from chronic kidney disease-Data from the GCKD study. J. Clin. Periodontol. 47, 19–29 (2020).
Schutz, J. D. S. et al. Association between severe periodontitis and chronic kidney disease severity in predialytic patients: A cross-sectional study. Oral. Dis. 26, 447–456 (2020).
He, I. et al. Demystifying the connection between periodontal disease and chronic kidney disease – An umbrella review. J. Periodontal Res. 58, 874–892 (2023).
Deschamps-Lenhardt, S., Martin-Cabezas, R., Hannedouche, T. & Huck, O. Association between periodontitis and chronic kidney disease: Systematic review and meta-analysis. Oral. Dis. 25, 385–402 (2019).
Kapellas, K., Singh, A., Bertotti, M., Nascimento, G. G. & Jamieson, L. M. Periodontal and chronic kidney disease association: A systematic review and meta-analysis. Nephrology 24, 202–212 (2019).
Clark, D., Radaic, A. & Kapila, Y. Cellular Mechanisms of Inflammaging and Periodontal Disease. Front. Dent. Med. https://doi.org/10.3389/fdmed.2022.844865 (2022).
Clark, D., Kotronia, E. & Ramsay, S. E. Frailty, aging, and periodontal disease: Basic biologic considerations. Periodontol. 2000 87, 143–156 (2021).
Li, S. et al. Periodontal disease and chronic kidney disease: mechanistic insights and novel therapeutic perspectives. Front. Cell Infect. Microbiol 15, 1611097 (2025).
Sharma, P. et al. Oxidative stress links periodontal inflammation and renal function. J. Clin. Periodontol. 48, 357–367 (2021).
Chapple, I. L. C., Hirschfeld, J., Cockwell, P., Dietrich, T. & Sharma, P. Interplay between periodontitis and chronic kidney disease. Nat. Rev. Nephrol. 21, 226–240 (2025).
D’Aiuto, F. et al. Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial. Lancet Diab. Endocrinol. 6, 954–965 (2018).
Hajishengallis, G. & Chavakis, T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat. Rev. Immunol. 21, 426–440 (2021).
Hajishengallis, G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat. Rev. Immunol. 15, 30–44 (2015).
El-Shinnawi, U. & Soory, M. Associations between periodontitis and systemic inflammatory diseases: response to treatment. Recent Pat. Endocr. Metab. Immune Drug Discov. 7, 169–188 (2013).
Li, L. et al. Periodontitis exacerbates and promotes the progression of chronic kidney disease through oral flora, cytokines, and oxidative stress. Front Microbiol 12, 656372 (2021).
Araújo, M. V. et al. End stage renal disease as a modifier of the periodontal microbiome. BMC Nephrol. 16, 80 (2015).
de Oliveira, C., Watt, R. & Hamer, M. Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey. BMJ 340, c2451 (2010).
Lira-Junior, R., Figueredo, C. M., Bouskela, E. & Fischer, R. G. Severe chronic periodontitis is associated with endothelial and microvascular dysfunctions: a pilot study. J. Periodontol. 85, 1648–1657 (2014).
Dorn, B. R., Dunn, W. A. Jr. & Progulske-Fox, A. Invasion of human coronary artery cells by periodontal pathogens. Infect. Immun. 67, 5792–5798 (1999).
Bui, F. Q. et al. Association between periodontal pathogens and systemic disease. Biomed. J. 42, 27–35 (2019).
Cullin, N., Azevedo Antunes, C., Straussman, R., Stein-Thoeringer, C. K. & Elinav, E. Microbiome and cancer. Cancer Cell 39, 1317–1341 (2021).
Chopra, A. et al. Exploring the presence of oral bacteria in non-oral sites of patients with cardiovascular diseases using whole metagenomic data. Sci. Rep. 14, 1476 (2024).
Ishigami, J. et al. CKD and Risk for Hospitalization With Infection: The Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Kidney Dis. 69, 752–761 (2017).
Baciu, S. F., Mesaros, A. S. & Kacso, I. M. Chronic kidney disease and periodontitis interplay-a narrative review. Int J. Environ. Res. Public Health. https://doi.org/10.3390/ijerph20021298 (2023).
Hu, J. et al. Location-specific oral microbiome possesses features associated with CKD. Kidney Int Rep. 3, 193–204 (2018).
Guo, S. et al. Characteristics of human oral microbiome and its non-invasive diagnostic value in chronic kidney disease. Biosci. Rep. https://doi.org/10.1042/bsr20210694 (2022).
Gan, Y. et al. Difference in oral microbiota composition between patients with stage 5 chronic kidney disease on hemodialysis and healthy controls. Am. J. Transl. Res. 15, 3342–3354 (2023).
Wangerin, C. et al. Long-term association of periodontitis with decreased kidney function. Am. J. Kidney Dis. 73, 513–524 (2019).
Ioannidou, E., Swede, H. & Dongari-Bagtzoglou, A. Periodontitis predicts elevated C-reactive protein levels in chronic kidney disease. J. Dent. Res. 90, 1411–1415 (2011).
Niedzielska, I. et al. The odontogenic-related microinflammation in patients with chronic kidney disease. Ren. Fail 36, 883–888 (2014).
Beernink, J. M., van Mil, D., Laverman, G. D., Heerspink, H. J. L. & Gansevoort, R. T. Developments in albuminuria testing: A key biomarker for detection, prognosis and surveillance of kidney and cardiovascular disease-A practical update for clinicians. Diab Obes. Metab. https://doi.org/10.1111/dom.16359 (2025).
Singh, D., Whooley, M. A., Ix, J. H., Ali, S. & Shlipak, M. G. Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol. Dial. Transpl. 22, 1087–1092 (2007).
Papapanou, P. N. et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J. Clin. Periodontol. 45, S162–s170 (2018).
Caton, J. G. et al. A new classification scheme for periodontal and peri-implant diseases and conditions – Introduction and key changes from the 1999 classification. J. Clin. Periodontol. 45, S1–s8 (2018).
Astley, M. E. et al. Age- and sex-specific reference values of estimated glomerular filtration rate for European adults. Kidney Int. 107, 1076–1087 (2025).
Kshirsagar, A. V. et al. Periodontal disease is associated with renal insufficiency in the Atherosclerosis Risk In Communities (ARIC) study. Am. J. Kidney Dis. 45, 650–657 (2005).
Sanz, M. et al. Treatment of stage I-III periodontitis-The EFP S3 level clinical practice guideline. J. Clin. Periodontol. 47(Suppl 22), 4–60 (2020).
Petreski, T., Piko, N., Ekart, R., Hojs, R. & Bevc, S. Review on inflammation markers in chronic kidney disease. Biomedicines. https://doi.org/10.3390/biomedicines9020182 (2021).
Martínez-García, M. & Hernández-Lemus, E. Periodontal inflammation and systemic diseases: an overview. Front Physiol. 12, 709438 (2021).
Tonelli, M., Sacks, F., Pfeffer, M., Jhangri, G. S. & Curhan, G. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 68, 237–245 (2005).
Amdur, R. L. et al. Inflammation and progression of CKD: The CRIC Study. Clin. J. Am. Soc. Nephrol. 11, 1546–1556 (2016).
Koshino, A. et al. Interleukin-6 and cardiovascular and kidney outcomes in patients with Type 2 diabetes: new insights from CANVAS. Diab Care 45, 2644–2652 (2022).
Delbove, T. et al. Effect of periodontal treatment on the glomerular filtration rate, reduction of inflammatory markers and mortality in patients with chronic kidney disease: A systematic review. PLoS One 16, e0245619 (2021).
Almeida, S., Figueredo, C. M., Lemos, C., Bregman, R. & Fischer, R. G. Periodontal treatment in patients with chronic kidney disease: a pilot study. J. Periodontal Res. 52, 262–267 (2017).
Chaudhry, A. et al. Potential effects of non-surgical periodontal therapy on periodontal parameters, inflammatory markers, and kidney function indicators in chronic kidney disease patients with chronic periodontitis. Biomedicines. https://doi.org/10.3390/biomedicines10112752 (2022).
França, L. F. C. et al. Periodontitis changes renal structures by oxidative stress and lipid peroxidation. J. Clin. Periodontol. 44, 568–576 (2017).
Randall, D. et al. Oral dysbiosis initiates periodontal disease in experimental kidney disease. Nephrol. Dial. Transpl. 40, 1187–1202 (2025).
Okura, T. et al. Association between cystatin C and inflammation in patients with essential hypertension. Clin. Exp. Nephrol. 14, 584–588 (2010).
Benzing, T. & Salant, D. Insights into glomerular filtration and albuminuria. N. Engl. J. Med. 384, 1437–1446 (2021).
Eke, P. I. et al. Periodontitis in US Adults: National Health and Nutrition Examination Survey 2009-2014. J. Am. Dent. Assoc. 149, 576–588.e576 (2018).
Jagodzinski, A. et al. Rationale and Design of the Hamburg City Health Study. Eur. J. Epidemiol. 35, 169–181 (2020).
Organisation for Economic Co-operation and Development: Classifying educational programmes: manual for ISCED-97 implementation in OECD countries; 1999 edition. (1999).
Boeing, H., Wahrendorf, J. & Becker, N. EPIC-Germany—A source for studies into diet and risk of chronic diseases. Eur. Investig. Cancer Nutr. Ann. Nutr. Metab. 43, 195–204 (1999).
Petersen, E. L. et al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme. Eur. Heart J. 43, 1124–1137 (2022).
Schmidt-Lauber, C. et al. Kidney outcome after mild to moderate COVID-19. Nephrol. Dial. Transpl. 38, 2031–2040 (2023).
Walther, C. et al. Association between periodontitis and depression severity – A cross-sectional study of the older population in Hamburg. Brain Behav. Immun. Health 34, 100689 (2023).
Schmidt-Lauber, C. et al. Prevalence and characteristics of chronic kidney disease in the Hamburg City Health Study. Nephrol. Dial. Transpl. 40, 1632–1634 (2025).
Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604–612 (2009).
Stevens, P. E. & Levin, A. & Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group, M. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann. Intern Med. 158, 825–830 (2013).
Fox, C. S. et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 380, 1662–1673 (2012).
Arnlov, J. et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 112, 969–975 (2005).
Holtfreter, B. et al. ACES: A new framework for the application of the 2018 periodontal status classification scheme to epidemiological survey data. J. Clin. Periodontol. 51, 512–521 (2024).
Kinane, D. F., Stathopoulou, P. G. & Papapanou, P. N. Periodontal diseases. Nat. Rev. Dis. Prim. 3, 17038 (2017).
CKD Work Group, K. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 105, S117-S314 (2024).
Genco, R. J. & Borgnakke, W. S. Risk factors for periodontal disease. Periodontol. 2000 62, 59–94 (2013).
Tingley, D., Yamamoto, T., Hirose, K., Keele, L. & Imai, K. mediation: R Package for Causal Mediation Analysis. J. Stat. Softw. 59, 1–38 (2014).